Humana Inc. Reaffirms Earnings and Targets Medicare Advantage Growth
Humana Inc. has reaffirmed its adjusted earnings forecast for the full year while outlining a multiyear plan aimed at restoring Medicare Advantage margins to sustainable levels by 2028. The company's strategy includes centralizing core activities and enhancing vendor relationships to significantly reduce costs. This effort aligns with an initiative to streamline infrastructure and clarify accountabilities.
A key component of Humana’s objectives is improving Star Ratings, with management reporting operational improvements across vital clinical metrics during the measurement period for future bonus years. The company's capital allocation strategy underscores efficiency, highlighted by the divestiture of non-core assets and the utilization of innovative liquidity facilities to support targeted acquisitions in the primary care sector.
During a recent earnings call, Humana's President and CEO, Jim Rechtin, along with CFO Celeste Mellet, shared insights into the company's progress and strategic priorities. Rechtin stated that the company is on track to meet its objectives, including achieving a sustainable 3% pretax margin in Medicare Advantage by 2028. Humana aims to retain top-quartile Stars results, defined as per member per month Stars revenue exceeding the peer group median by 10%.
Humana's membership growth in 2026 aligns with expectations, and the company focuses on maintaining this trajectory into 2027, prioritizing margin improvements. Clinical excellence and operating efficiency are set to drive targeted margin expansion in the upcoming year. The company has centralized various operations, including utilization management, to enhance process consistency and achieve General and Administrative savings.
Additionally, Humana continues its efforts to divest non-core assets, recently agreeing to sell its minority interest in Gentiva for approximately $900 million. This divestiture will largely finance the acquisition of MaxHealth. Furthermore, Humana has expanded its Medicaid platform, securing a statewide Illinois Medicaid managed care contract set to commence in January 2027.
As part of its leadership expansion, Humana announced the addition of Paul Smith and Fred Crawford to its Board of Directors. Their experience in commercial strategy and financial operations is expected to contribute valuable insights as Humana progresses in its journey toward becoming a consumer-focused healthcare company.
Lastly, Humana has been implementing cost management measures, producing significant savings through operational model changes, centralization, and vendor optimization. This restructuring has already generated hundreds of millions in value in 2026, laying the groundwork for sustained financial performance and improved service delivery.